Liposomal Bupivacaine for Pain Control After Total Shoulder Arthroplasty

NACompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

April 15, 2019

Study Completion Date

April 15, 2019

Conditions
OsteoarthritisArthropathyShoulder PainClosed Fracture Proximal Humerus, Four Part
Interventions
DRUG

Liposomal bupivacaine

Patients in this group will receive a periarticular injection containing liposomal bupivacaine during surgery. The injection will be administered by the surgeon.

DRUG

Interscalene Nerve Block

Patients in this group will receive an interscalene nerve block containing the local anesthetic ropivacaine prior to surgery. The nerve block will be administered by a fellowship-trained anesthesiologist.

Trial Locations (2)

21044

Johns Hopkins University, Columbia

75390

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

University of Texas Southwestern Medical Center

OTHER

lead

Johns Hopkins University

OTHER

NCT02762071 - Liposomal Bupivacaine for Pain Control After Total Shoulder Arthroplasty | Biotech Hunter | Biotech Hunter